SUVEN PHARMACEUTICALS LIMITEDSUVEN PHARMACEUTICALS LIMITEDSUVEN PHARMACEUTICALS LIMITED

SUVEN PHARMACEUTICALS LIMITED

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪332.28 B‬INR
9.55INR
‪3.00 B‬INR
‪10.36 B‬INR
‪101.49 M‬
Beta (1Y)
0.43
Employees (FY)
‪1.05 K‬
Change (1Y)
‪−1.52 K‬ −59.16%
Revenue / Employee (1Y)
‪9.85 M‬INR
Net income / Employee (1Y)
‪2.85 M‬INR

About SUVEN PHARMACEUTICALS LTD


CEO
Sudhir Kumar Singh
Headquarters
Hyderabad
Founded
2018
ISIN
INE03QK01018
FIGI
BBG00S6SV6K0
Suven Pharmaceuticals Ltd. manufactures chemical products. It specializes in providing pharmaceutical solutions to global life science companies. The firm engages in Contract Research & Manufacturing Services (CRMS) business where research and development is customized to the needs of global pharmaceutical customers. Its business segments include pharmaceutical solutions, active pharma ingredients, intermediates and formulations. The company was founded on November 6, 2018 and is headquartered in Hyderabad, Telangana.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of SUVENPHAR is 1,307.80 INR — it has increased by 0.19% in the past 24 hours. Watch SUVEN PHARMACEUTICALS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SUVEN PHARMACEUTICALS LIMITED stocks are traded under the ticker SUVENPHAR.
SUVENPHAR stock has risen by 0.30% compared to the previous week, the month change is a 1.91% rise, over the last year SUVEN PHARMACEUTICALS LIMITED has showed a 90.92% increase.
We've gathered analysts' opinions on SUVEN PHARMACEUTICALS LIMITED future price: according to them, SUVENPHAR price has a max estimate of 1,330.00 INR and a min estimate of 1,330.00 INR. Watch SUVENPHAR chart and read a more detailed SUVEN PHARMACEUTICALS LIMITED stock forecast: see what analysts think of SUVEN PHARMACEUTICALS LIMITED and suggest that you do with its stocks.
SUVENPHAR reached its all-time high on Dec 2, 2024 with the price of 1,359.00 INR, and its all-time low was 87.05 INR and was reached on Mar 24, 2020. View more price dynamics on SUVENPHAR chart.
See other stocks reaching their highest and lowest prices.
SUVENPHAR stock is 4.22% volatile and has beta coefficient of 0.43. Track SUVEN PHARMACEUTICALS LIMITED stock price on the chart and check out the list of the most volatile stocks — is SUVEN PHARMACEUTICALS LIMITED there?
Today SUVEN PHARMACEUTICALS LIMITED has the market capitalization of ‪332.28 B‬, it has decreased by −0.20% over the last week.
Yes, you can track SUVEN PHARMACEUTICALS LIMITED financials in yearly and quarterly reports right on TradingView.
SUVEN PHARMACEUTICALS LIMITED is going to release the next earnings report on Feb 10, 2025. Keep track of upcoming events with our Earnings Calendar.
SUVENPHAR net income for the last quarter is ‪822.10 M‬ INR, while the quarter before that showed ‪607.70 M‬ INR of net income which accounts for 35.28% change. Track more SUVEN PHARMACEUTICALS LIMITED financial stats to get the full picture.
SUVEN PHARMACEUTICALS LIMITED dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.21% and 6.19% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 9, 2024, the company has ‪1.05 K‬ employees. See our rating of the largest employees — is SUVEN PHARMACEUTICALS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SUVEN PHARMACEUTICALS LIMITED EBITDA is ‪3.22 B‬ INR, and current EBITDA margin is 39.68%. See more stats in SUVEN PHARMACEUTICALS LIMITED financial statements.
Like other stocks, SUVENPHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SUVEN PHARMACEUTICALS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SUVEN PHARMACEUTICALS LIMITED technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SUVEN PHARMACEUTICALS LIMITED stock shows the buy signal. See more of SUVEN PHARMACEUTICALS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.